Alembic Gets 5 USFDA Observations for Gujarat Plant
By Rediff Money Desk, New Delhi Nov 23, 2024 21:02
Alembic Pharmaceuticals received five observations from the USFDA after an inspection of its Gujarat-based manufacturing plant. The company will respond to the observations within the stipulated period.
New Delhi, Nov 23 (PTI) Alembic Pharmaceuticals on Saturday said the US health regulator has issued Form 483 with five observations after inspecting its Gujarat-based manufacturing plant.
The US Food and Drug Administration (USFDA) conducted inspection at Jarod-based solid oral formulation facility from November 14-22, 2024, the drug firm said in a regulatory filing.
The USFDA issued a Form 483 with five procedural observations, it added.
The company will provide a comprehensive response to the USFDA for the observations within the stipulated period, it said.
The US Food and Drug Administration (USFDA) conducted inspection at Jarod-based solid oral formulation facility from November 14-22, 2024, the drug firm said in a regulatory filing.
The USFDA issued a Form 483 with five procedural observations, it added.
The company will provide a comprehensive response to the USFDA for the observations within the stipulated period, it said.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 8.82 (+ 4.88)
- 32760312
- AvanceTechnologies
- 0.71 ( 0.00)
- 7912528
- Srestha Finvest
- 0.65 (+ 1.56)
- 7150734
- TVS Supply Chain Sol
- 143.75 ( -1.78)
- 6848998
- GTL Infrastructure
- 1.70 ( -1.73)
- 6333863
MORE NEWS

Sensex, Nifty Rebound After 6-Day Slump:...
Indian stock markets rallied in early trade on Thursday, driven by lower-than-expected...

Goa Approves Rs 733 Crore Projects, Creating...
The Goa Investment Promotion Board has approved nine projects worth Rs 733 crore,...

Rupee Rises to 86.81 Against US Dollar
The Indian rupee strengthened against the US dollar in early trade on Thursday, driven...